Ahead of the government's response this week to a Senate inquiry into access to reproductive health care in Australia, the government has announced new measures to make it easier to get an ...
The FDA gave premarket approval to the first medical device for the treatment of women with symptomatic moderate-to-severe intrauterine adhesions, known as Asherman syndrome, maker Womed announced on ...
A comprehensive analysis of birth control methods has unveiled important insights about the relationship between hormonal intrauterine devices and breast cancer risk, prompting medical professionals ...
Hormonal intrauterine devices (IUDs), unlike oral contraceptives, were not linked with an increased risk for melasma in women with menorrhagia, this study found. Researchers analyzed data from the ...
Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has directed strict regulatory oversight on ...
Hormonal contraception, including birth control pills and intrauterine devices (IUDs), is not associated with an increased ...
The idea of a medical device that is fully recyclable or completely biodegradable appeals to many in the industry – even patients. Although progress has been slow, the medical device industry is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results